Coherus Biosciences Inc. (CHRS)
NASDAQ · Healthcare
Coherus Biosciences Inc. Net Income 2012–2025
Coherus Biosciences Inc. annual/quarterly net income history and growth rate from 2012 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Coherus Biosciences Inc. net income for the quarter ending March 31, 2026 was -38.3 M, a 32.25% decrease year-over-year.
- Coherus Biosciences Inc. net income for the twelve months ending March 31, 2026 was 167.3 M, a 322.98% increase year-over-year.
- Coherus Biosciences Inc. annual net income for 2025 was 168.0 M, a 489.41% increase from 2024.
- Coherus Biosciences Inc. annual net income for 2024 was 28.5 M, a 111.98% decrease from 2023.
- Coherus Biosciences Inc. annual net income for 2023 was -237.9 M, a 18.46% decrease from 2022.
- Coherus Biosciences Inc. annual net income for 2022 was -291.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Coherus Biosciences Inc. Net Income — FAQ
Coherus Biosciences Inc. (CHRS) net income over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Coherus Biosciences Inc.'s net income?
Coherus Biosciences Inc. (CHRS) reported net income of $168M for fiscal 2025.
Where can I see CHRS's net income history?
The chart and table above show Coherus Biosciences Inc.'s net income by year and by quarter, including the growth rate.